Jiangsu GenScript Probio Biotech Co., Lt – Trademark Portfolio
Entity Type: 99
Jiangsu GenScript Probio Biotech Co., Lt holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include POWERS.
Bldg. 52#, 99 Chuqiao Road,
Ding Mao Subdistrict,Zhenjiang New District, 212000 Jiangsu Province
Showing of trademarks Trademarks
Trademark Classifications
Jiangsu GenScript Probio Biotech Co., Lt's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Jiangsu GenScript Probio Biotech Co., Lt have?
Jiangsu GenScript Probio Biotech Co., Lt has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Jiangsu GenScript Probio Biotech Co., Lt file in?
Jiangsu GenScript Probio Biotech Co., Lt files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Jiangsu GenScript Probio Biotech Co., Lt's most well-known trademarks?
Jiangsu GenScript Probio Biotech Co., Lt's registered trademark portfolio includes well-known marks such as POWERS. These are among 2 currently registered trademarks in the portfolio.
What is Jiangsu GenScript Probio Biotech Co., Lt's trademark registration success rate?
Jiangsu GenScript Probio Biotech Co., Lt has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.